Selected research
Industry Research
Prostaglandin D2 Receptor 2 Industry Research Report 2026
Market perspective
The global Prostaglandin D2 Receptor 2 market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Prostaglandin D2 Receptor 2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Prostaglandin D2 Receptor 2 is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Prostaglandin D2 Receptor 2 is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Prostaglandin D2 Receptor 2 include Novartis AG, Merck & Co., Inc., Taisho Pharmaceutical Holdings Co., Ltd., Pulmagen Therapeutics LLP, Panmira Pharmaceuticals, LLC., Oxagen Limited, Ligand Pharmaceuticals, Inc., Brickell Biotech, Inc. and Allergan Plc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Prostaglandin D2 Receptor 2 market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prostaglandin D2 Receptor 2 Market by Company
Novartis AG
Merck & Co., Inc.
Taisho Pharmaceutical Holdings Co., Ltd.
Pulmagen Therapeutics LLP
Panmira Pharmaceuticals, LLC.
Oxagen Limited
Ligand Pharmaceuticals, Inc.
Brickell Biotech, Inc.
Allergan Plc
Prostaglandin D2 Receptor 2 Segment by Type
ADC-7405
BBI-5000
MK-1029
OC-2417
Others
Prostaglandin D2 Receptor 2 Segment by Application
Atopic Dermatitis
Chronic Obstructive Pulmonary Disease
Allergic Asthma
Others
Prostaglandin D2 Receptor 2 Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prostaglandin D2 Receptor 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prostaglandin D2 Receptor 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prostaglandin D2 Receptor 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Prostaglandin D2 Receptor 2 manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Prostaglandin D2 Receptor 2 by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Prostaglandin D2 Receptor 2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ADC-7405
- BBI-5000
- MK-1029
- OC-2417
- Others
Applications
- Atopic Dermatitis
- Chronic Obstructive Pulmonary Disease
- Allergic Asthma
- Others
Companies covered
- Novartis AG
- Merck & Co., Inc.
- Taisho Pharmaceutical Holdings Co., Ltd.
- Pulmagen Therapeutics LLP
- Panmira Pharmaceuticals, LLC.
- Oxagen Limited
- Ligand Pharmaceuticals, Inc.
- Brickell Biotech, Inc.
- Allergan Plc
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Prostaglandin D2 Receptor 2 Market Size (2021-2032)
- 2.2.2 Global Prostaglandin D2 Receptor 2 Sales (2021-2032)
- 2.2.3 Global Prostaglandin D2 Receptor 2 Market Average Price (2021-2032)
- 2.3 Prostaglandin D2 Receptor 2 by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 ADC-7405
- 2.3.3 BBI-5000
- 2.3.4 MK-1029
- 2.3.5 OC-2417
- 2.3.6 Others
- 2.4 Prostaglandin D2 Receptor 2 by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Atopic Dermatitis
- 2.4.3 Chronic Obstructive Pulmonary Disease
- 2.4.4 Allergic Asthma
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Prostaglandin D2 Receptor 2 Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Prostaglandin D2 Receptor 2 Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Prostaglandin D2 Receptor 2 Revenue of Manufacturers (2021-2026)
- 3.4 Global Prostaglandin D2 Receptor 2 Average Price by Manufacturers (2021-2026)
- 3.5 Global Prostaglandin D2 Receptor 2 Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Prostaglandin D2 Receptor 2, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Prostaglandin D2 Receptor 2, Product Type & Application
- 3.8 Global Manufacturers of Prostaglandin D2 Receptor 2, Established Date
- 3.9 Global Prostaglandin D2 Receptor 2 Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis AG
- 4.1.1 Novartis AG Company Information
- 4.1.2 Novartis AG Business Overview
- 4.1.3 Novartis AG Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis AG Prostaglandin D2 Receptor 2 Product Portfolio
- 4.1.5 Novartis AG Recent Developments
- 4.2 Merck & Co., Inc.
- 4.2.1 Merck & Co., Inc. Company Information
- 4.2.2 Merck & Co., Inc. Business Overview
- 4.2.3 Merck & Co., Inc. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Merck & Co., Inc. Prostaglandin D2 Receptor 2 Product Portfolio
- 4.2.5 Merck & Co., Inc. Recent Developments
- 4.3 Taisho Pharmaceutical Holdings Co., Ltd.
- 4.3.1 Taisho Pharmaceutical Holdings Co., Ltd. Company Information
- 4.3.2 Taisho Pharmaceutical Holdings Co., Ltd. Business Overview
- 4.3.3 Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Product Portfolio
- 4.3.5 Taisho Pharmaceutical Holdings Co., Ltd. Recent Developments
- 4.4 Pulmagen Therapeutics LLP
- 4.4.1 Pulmagen Therapeutics LLP Company Information
- 4.4.2 Pulmagen Therapeutics LLP Business Overview
- 4.4.3 Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Product Portfolio
- 4.4.5 Pulmagen Therapeutics LLP Recent Developments
- 4.5 Panmira Pharmaceuticals, LLC.
- 4.5.1 Panmira Pharmaceuticals, LLC. Company Information
- 4.5.2 Panmira Pharmaceuticals, LLC. Business Overview
- 4.5.3 Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Product Portfolio
- 4.5.5 Panmira Pharmaceuticals, LLC. Recent Developments
- 4.6 Oxagen Limited
- 4.6.1 Oxagen Limited Company Information
- 4.6.2 Oxagen Limited Business Overview
- 4.6.3 Oxagen Limited Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Oxagen Limited Prostaglandin D2 Receptor 2 Product Portfolio
- 4.6.5 Oxagen Limited Recent Developments
- 4.7 Ligand Pharmaceuticals, Inc.
- 4.7.1 Ligand Pharmaceuticals, Inc. Company Information
- 4.7.2 Ligand Pharmaceuticals, Inc. Business Overview
- 4.7.3 Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Product Portfolio
- 4.7.5 Ligand Pharmaceuticals, Inc. Recent Developments
- 4.8 Brickell Biotech, Inc.
- 4.8.1 Brickell Biotech, Inc. Company Information
- 4.8.2 Brickell Biotech, Inc. Business Overview
- 4.8.3 Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Product Portfolio
- 4.8.5 Brickell Biotech, Inc. Recent Developments
- 4.9 Allergan Plc
- 4.9.1 Allergan Plc Company Information
- 4.9.2 Allergan Plc Business Overview
- 4.9.3 Allergan Plc Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Allergan Plc Prostaglandin D2 Receptor 2 Product Portfolio
- 4.9.5 Allergan Plc Recent Developments
5 Global Prostaglandin D2 Receptor 2 Market Scenario by Region
- 5.1 Global Prostaglandin D2 Receptor 2 Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Prostaglandin D2 Receptor 2 Sales by Region: 2021-2032
- 5.2.1 Global Prostaglandin D2 Receptor 2 Sales by Region: 2021-2026
- 5.2.2 Global Prostaglandin D2 Receptor 2 Sales by Region: 2027-2032
- 5.3 Global Prostaglandin D2 Receptor 2 Revenue by Region: 2021-2032
- 5.3.1 Global Prostaglandin D2 Receptor 2 Revenue by Region: 2021-2026
- 5.3.2 Global Prostaglandin D2 Receptor 2 Revenue by Region: 2027-2032
- 5.4 North America Prostaglandin D2 Receptor 2 Market Facts & Figures by Country
- 5.4.1 North America Prostaglandin D2 Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Prostaglandin D2 Receptor 2 Sales by Country (2021-2032)
- 5.4.3 North America Prostaglandin D2 Receptor 2 Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Prostaglandin D2 Receptor 2 Market Facts & Figures by Country
- 5.5.1 Europe Prostaglandin D2 Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Prostaglandin D2 Receptor 2 Sales by Country (2021-2032)
- 5.5.3 Europe Prostaglandin D2 Receptor 2 Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Prostaglandin D2 Receptor 2 Market Facts & Figures by Country
- 5.6.1 Asia Pacific Prostaglandin D2 Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Prostaglandin D2 Receptor 2 Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Prostaglandin D2 Receptor 2 Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Prostaglandin D2 Receptor 2 Market Facts & Figures by Country
- 5.7.1 South America Prostaglandin D2 Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Prostaglandin D2 Receptor 2 Sales by Country (2021-2032)
- 5.7.3 South America Prostaglandin D2 Receptor 2 Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Prostaglandin D2 Receptor 2 Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Prostaglandin D2 Receptor 2 Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Prostaglandin D2 Receptor 2 Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Prostaglandin D2 Receptor 2 Sales by Type (2021-2032)
- 6.1.1 Global Prostaglandin D2 Receptor 2 Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Prostaglandin D2 Receptor 2 Sales Market Share by Type (2021-2032)
- 6.2 Global Prostaglandin D2 Receptor 2 Revenue by Type (2021-2032)
- 6.2.1 Global Prostaglandin D2 Receptor 2 Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Prostaglandin D2 Receptor 2 Revenue Market Share by Type (2021-2032)
- 6.3 Global Prostaglandin D2 Receptor 2 Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Prostaglandin D2 Receptor 2 Sales by Application (2021-2032)
- 7.1.1 Global Prostaglandin D2 Receptor 2 Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Prostaglandin D2 Receptor 2 Sales Market Share by Application (2021-2032)
- 7.2 Global Prostaglandin D2 Receptor 2 Revenue by Application (2021-2032)
- 7.2.1 Global Prostaglandin D2 Receptor 2 Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Prostaglandin D2 Receptor 2 Revenue Market Share by Application (2021-2032)
- 7.3 Global Prostaglandin D2 Receptor 2 Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Prostaglandin D2 Receptor 2 Value Chain Analysis
- 8.1.1 Prostaglandin D2 Receptor 2 Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Prostaglandin D2 Receptor 2 Production Mode & Process
- 8.2 Prostaglandin D2 Receptor 2 Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Prostaglandin D2 Receptor 2 Distributors
- 8.2.3 Prostaglandin D2 Receptor 2 Customers
9 Global Prostaglandin D2 Receptor 2 Analyzing Market Dynamics
- 9.1 Prostaglandin D2 Receptor 2 Industry Trends
- 9.2 Prostaglandin D2 Receptor 2 Industry Drivers
- 9.3 Prostaglandin D2 Receptor 2 Industry Opportunities and Challenges
- 9.4 Prostaglandin D2 Receptor 2 Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst